3The Rotterdam ESHRE/ASRM-Sponsored PCOS Con-sensus Workshop Group.Revised 2003 consensus on di- agnostic criteria and long-term health risks related to polycystic ovary syndrome [J]. Fertil Steril,2004,81(1): 19-25.
4Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod,2004,19 (1) : 41-47.
5Carmina E.Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines [J].Minerva Ginecol,2004,56(1): 1-6.
6Azziz R, Carmina E, Dewailly D,et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report[J]. Fertil Steril, 2009,91 (2) :456-488.
8Swanson M, Sauerbrei EE, Cooperberg P. Medical impli- cations of ultrasonically detected polycystic ovaries [J]. J Clin Ultrasound, 1981,9(5):219 222.
9Adams J, Franks S, Polson DW, et al.Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone [J].Lancet, 1985,2(8469-8470):1375-1379.
10Battaglia C.The role of ultrasound and Doppler analysis in the diagnosis of polycystic ovary syndrome[J].Ultra- sound Obstet Gynecol, 2003,22(3):225-232.
